Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
Lassa virus (LASV) is a rodent-borne arenavirus circulating in West African regions that causes Lassa fever (LF). LF is normally asymptomatic at the initial infection stage, but can progress to severe disease with multiorgan collapse and hemorrhagic fever. To date, the therapeutic choices are limite...
Main Authors: | Meirong Wang, Ruihua Li, Yaohui Li, Changming Yu, Xiangyang Chi, Shipo Wu, Shulin Liu, Junjie Xu, Wei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/3/484 |
Similar Items
-
Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
by: O. Popova, et al.
Published: (2025-01-01) -
Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
by: Salam, A
Published: (2024) -
Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
by: Francis Ifedayo Ibukun
Published: (2020-03-01) -
A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
by: N’Faly Magassouba, et al.
Published: (2020-09-01) -
Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
by: Anges Yadouleton, et al.
Published: (2020-01-01)